The Author's response: Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The Application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR

Journal of Korean Medical Science

Volumn 35, Issue 7, 2020, Pages

  Lim, Jaegyun ^a   Jeon, Seunghyun ^b   Shin, Hyun Young ^a   Kim, Moon Jung ^a   Seong, Yu Min ^b   Lee, Wang Jun ^b   Choe, Kang Won ^b   Kang, Yu Min ^b   Lee, Baeckseung ^c   Park, Sang Joon ^b  

^a Hanyang University College of Medicine   (South Korea)

^b Seonam University of Medicine Myongji Hospital   (South Korea)

^c CancerROP   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LOPINAVIR; RITONAVIR; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

BETACORONAVIRUS; CORONAVIRINAE; CORONAVIRUS DISEASE 2019; HUMAN; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOUTH KOREA;

BETACORONAVIRUS; CORONAVIRUS; HUMANS; LOPINAVIR; PNEUMONIA; REPUBLIC OF KOREA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RITONAVIR;

EID: 85079742900     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2020.35.e89     Document Type: Letter

References (3)

1. Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. Case of the index patient who caused tertiary transmission of Coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 2020;35(6):e79.
2. Li G, Clercq ED. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. Forthcoming 2020.
3. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. Forthcoming 2020.